Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 35.6147.5621.21-60.59-243.82

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 35.61 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202535.61
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2025 35.61
-25.13
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,637.4 Cr 8.8% -7.9% -31.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

8.8%

-7.9%

-31.7%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses